alexa Stem Cells and Regenerative Medicine | OMICS International
Stem Cell Research and Regenerative Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Stem Cells and Regenerative Medicine

Miguel Guillermo Garber*

Revitacell Clinic, Department of Regenerative Medicine, Madrid, Spain

*Corresponding Author:
Miguel Guillermo Garber
Medical Director, Revitacell Clinic and Clinical Director of Regenerative Medicine
Madrid, Spain
E-mail: [email protected]

Received date: November 02, 2016; Accepted date: November 08, 2016; Published date: November 16, 2016

Citation: Garber MG (2016) Stem Cells and Regenerative Medicine. Stem Cell Res Regen Med 1:e101

Copyright: © 2016 Garber MG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Stem Cell Research and Regenerative Medicine

Editorial

First described back in 2002 in the manuscript Molecular Biology of the Cell, UCLA researchers introduced a new innovative adult stem cell population found in adipose tissue, known as adipose-derived stem cells (ADSC). Ever since, ADSCs have become the most prominent type of adult stem cell used in the field. No longer is adipose tissue seen as only a mass of cells involved in fat storage, rather it is seen as a sophisticated ensemble of cellular components with highly specialized and complex functions such as stromal-vascular fraction. Adipose tissue is a source of freshly isolated, heterogeneous stromal vascular fraction cells, and relatively homogeneous adipose stromal stem cells. Both populations display regenerative faculty in soft and hard tissue repair, ischemic injury and autoimmune diseases [1]. While they are known to accomplish both the release of paracrine factors as well as direct lineage differentiation, present-day evidence favors the former paracrine mechanism as its primary method of action.

Due to its abundance, accessibility and reliability, adipose tissue is a great source of multipotent adult stem cells and thus, used by many researchers for tissue engineering purposes. Several scientific studies validate the potential of adipose adult stem cells in regenerative medicine [2-4].

It has become apparent that to effectively translate ADSCs into clinical practice requires relying on technologies that can simplify and maximize the efficacy of the ADSCs. The most optimal methods in translational technology that minimize complications include: closedsystem operations, biosensors and real-time monitoring, biomimetics and rapid manufacturing. These methods greatly reduce the required resources for in vitro cell handling and effectively minimize human error. For example, through closed-system isolation devices, clinicians can both isolate a patient’s cells and re-administer the cells back into the patient in one surgery. The successful isolation of stromal vascular fraction (SVF) from adipose tissue with these devices has already been seen in a number of clinical trials and treatments for tissue repair. Although much advancement in ADSC research has been made in the last few years, more innovation in successful ADSC translation is needed [4-7].

Translational research on ADSC could enable clinicians to treat patients with ADSC therapies for an array of conditions ranging from tissue engineering to immunomodulatory applications. As ADSCs work their way into clinical practice, it is essential that researchers, physicians, the industry, and regulatory agencies work together to bring promising ADSC therapies to patients in a safe and effective manner.

Considering that chronic non-communicable diseases are the biggest challenge of the 21st century, I have no doubt that this decade will be renowned for its advancements in regenerative medicine and adipose-derived adult stem cell research [8].

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Journals

Recommended Conferences

Article Usage

  • Total views: 8054
  • [From(publication date):
    June-2017 - Dec 18, 2017]
  • Breakdown by view type
  • HTML page views : 7985
  • PDF downloads : 69
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version